The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: A phase-III intergroup study
K B Miller(Tufts Medical Center), M J O'Connell(Mayo Clinic in Arizona), John M. Bennett(University of Rochester Medical Center), David R. Head(University of Southern California), Richard S. Neiman(University Medical Center), Peter A. Cassileth(City Of Hope National Medical Center), Jane N. Winter(Northwestern University), Francis S. Morrison(Jackson Memorial Hospital), K. Kyungmann(Dana-Farber Cancer Institute)
Cited by 116
Related Papers
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k
Age and acute myeloid leukemia
|Blood|2006|1.4k
Diagnostic criteria and classification of mastocytosis: a consensus proposal
|Leukemia Research|2001|1.1k